Method for treating urinary incontinence in women and implantable device intended to correct urinary incontinence

Information

  • Patent Grant
  • 7621864
  • Patent Number
    7,621,864
  • Date Filed
    Friday, January 21, 2005
    19 years ago
  • Date Issued
    Tuesday, November 24, 2009
    14 years ago
Abstract
The invention relates to a method and device for treating urinary incontinence in women.
Description

The invention relates to a method for treating urinary incontinence in women. It also relates to an implantable device intended to correct urinary incontinence in women. The said device is more particularly suited to the treatment of stress urinary incontinence.


Various types of device have been proposed for treating phenomena of urinary incontinence in women.


Thus, for example, document U.S. Pat. No. 5,899,909 describes a tape of constant width, made of a material of the meshed or knitted polypropylene type ensuring fibroblast colonization and thus anchorage into the tissues along its entire length. Once an incision has been made in the wall of the vagina this tape is positioned under the urethra, the tape being led upwards on each side of the bladder to be anchored into the abdominal wall.


The method of fitting this tape is relatively tricky. Specifically, the needles being led vertically up alongside the bladder may not only pierce the latter, but may above all pierce the iliac artery or even the small intestine. In consequence, it is essential that cystoscopy be performed during the intervention.


Document WO 98/35632 describes a device in the form of a tape, the central region of which is wider than the body of the tape, the assembly being made of a biocompatible material, particularly a woven material, allowing for fibroblast colonization.


As before, each of the ends of the tape is led up alongside the bladder to be secured at the abdominal wall or, more specifically, in the bone of the pubis. Thus, the same drawbacks as before may be encountered.


One of the objects of the invention is to artificially reconstruct the pelvic fascia by fitting tapes aimed at restoring, as faithfully as possible, the effective and natural situation of the endo-pelvic fascia, in its role of fibrous plug obturating the urogenital opening, the said fascia resting on either side of the said opening on the floor of the lifting muscles.


Another of the stated objects of the present invention lies in solving the problems associated with subsequent surgical re-intervention in the region of the urethra; given the fact that the tapes proposed by the Prior Art are made, along their entire length, of a material capable of being colonized by fibroblasts, the problem arises of performing an intervention in this region if the tape, because of the fibroblast colonization, is anchored to the periurethral wall. A solution to this new problem is all the more important now that it has been found that the phenomenon of urinary incontinence may evolve to the fitting of an artificial sphincter. A problem such as this is neither disclosed nor suggested in the Prior Art.


Furthermore, the literature has described possible phenomena of the migration of the substance of which the tape is made, particularly polypropylene, into the viscera.


In order to solve all of these problems, the Applicant is proposing a method and an implantable device, intended to correct urinary incontinence in women.


This method for treating urinary incontinence in women comprises the following steps:

    • making a mediane paraurethral incision, practically in the middle third of the urethra, measured from the meatus, so as to allow the passage of a tape between the Alban fascia and the periurethral fascias;
    • extending each of the free ends of the said tape in the region of the two obturator foramen of the iliac wing and leading them out into the groin opposite the corresponding foramen so that they essentially form a V shape, the point of which V passes under the urethra without changing the position thereof.


In other words, and contrary to the surgical techniques employed in the state of the art, the tape is not led up alongside the bladder to form a U and thus be situated in close proximity to vital organs, but is on the contrary diverted from the bladder to form a V. Hence, no risk of damaging the bladder, the iliac artery or the small intestine is run. In consequence, it is not necessary to perform cystoscopy during the intervention.


According to the invention, in order to make it easier to fit the tape which acts as an implant, a space is made between, on the one hand, the Alban fascia, the perineal muscular plane and the anterior insertion of the puborectal muscle and, on the other hand, the periurethral fascias.


According to an advantageous version of the invention, the central region of the tape or implant, which region is intended to be inserted between the Alban fascia and the periurethral fascias, is coated with a substance capable of preventing any adhesion of the said fascias to the tape.


Thus it becomes possible to avoid any cell growth on the tape between the wall of the vagina and the wall of the urethra, hence avoiding any anchorage of the tape in this region and thus to allow subsequent surgical re-intervention. Furthermore, coating it with such a substance in the region of the urethra makes it possible to avoid any migration of polypropylene into the viscera.


The device according to the invention is characterized in that it is in the form of a tape of which the central region, intended to be inserted between the Alban fascia and the periurethral fascia, is coated with a substance capable of preventing any adhesion of the said fascias to the tape.


In a first embodiment, the substance that prevents adhesion of the fascias to the tape is silicone.


In a second embodiment, the substance is made of vegetable or animal growth factors.


Of course, any substance capable of avoiding the adhesion of the fascias to the tape may be envisaged.


The tape is coated on both side, advantageously on one side.


Furthermore, the tape is made of any materials such as those known to those skilled in the art and, in particular but without applying any limitation, any material chosen from the group containing polyethylene and polypropylene.


According to another feature, when the tape is made of polypropylene, the polypropylene is either meshed or knitted or alternatively is in the form of sprayed fibres. Nevetheless, the tape can also be made of absorbable material.


In one advantageous embodiment, the central region of the tape is not as wide as the rest of the tape and this is so as to limit the area of contact in the region of the Alban fascia and of the periurethral fascia.


Furthermore, and according to another feature, each of the ends of the tape has a tapered point intended to be anchored in the groin facing the corresponding obturator foramen.


According to a preferred embodiment, the tape has a length equal to 60 cm and a width equal to 2.5 cm, and has a central region which is not as wide, being 1 cm wide over a length equal to 3 cm. Advantageously, the central region has a length equal to 15 mm.





The invention and its ensuing advantages will emerge better from the following example in support of the appended figures.



FIG. 1 is a diagrammatic depiction of the tape of the invention.



FIG. 2 is a diagrammatic depiction of the position of the tape after fitting.





As shown in FIG. 1, the device of the invention is in the form of a tape (1) of a length equal to 60 cm and of a width equal to 2.5 cm. This tape is made, along its entire length, of sprayed polypropylene fibres.


According to an advantageous feature, the tape has, at its centre (2), a narrowing of length equal to 3 cm and of width equal to 1 cm, this portion being coated on both sides with a silicone-containing substance. Furthermore, each of its free ends (3, 4) is tapered.


Fitting the device requires mini-invasive surgery, the main steps of which are described hereinafter.


First of all, a mediane paraurethral incision is made in the region of the middle third of the urethra.


One of the two obturator foramen, and more specifically the lower internal part is then identified by a finger slipped into the vaginal incision and an incision is made in the perineal skin opposite it, and so in the groin, so as to form an orifice through which an Emmet needle is then passed. This needle is introduced through this cutaneous incision firstly perpendicular to the perineum for about 15 mm (passing through the internal obturator muscle as far as just outside the ischiopubic branch), then the needle is allowed to describe its curvature, guided in this by the finger introduced opposite the obturator muscle through the vaginal incision. The pointed end of the tape is then slipped into the eye of the needle, emerging from the said vaginal incision, then pulled back through the thickness of muscle, the retractor and the internal obturator up to the surface of the skin.


The tape is then placed between the Alban fascia and the periurethral fascias to position it in such a way that its central region, coated with silicone as appropriate, faces the said fascias. The tape is positioned without pulling behind the urethra.


An incision is then made in the perineal skin facing the second obturator foramen, into which incision an Emmet needle is inserted. The free end of the tape is then slipped into the eye of the needle which is pulled back in the same way as before.


The excess tape is then cut off flush with the skin then the skin is immobilized to disconnect it from the tape. The incision is finally closed with a stitch of quickly absorbable suture.



FIG. 2 diagrammatically depicts the position, in cross section, of the tape after it has been fitted. As shown in this figure, once in place, the tape adopts the shape of a V, the branches of which are very far apart.


Furthermore, it can also be seen that when the tape according to one of the advantageous embodiments of the invention is used, the silicone-coated segment of the tape is positioned between the uterus (5) and the vagina (6), while its ends (3, 4) are secured in the region of the groin (7, 8) facing the obturator foramen.


Thanks to the robustness and texture of the tape, tension can be strong without there being any risk of rupture. The tape is positioned under the control of sight without employing cystoscopy. It is essential that there be no pulling on this tape which has to be slipped down under the urethra without altering the position thereof.


It is apparent from the foregoing that the method according to the invention for treating urinary incontinence in women differs from the methods proposed in the state of the art through the simplicity of fitting of the tape, using mini-invasive surgery. Furthermore, it provides the urethra with firm suspension while at the same time maintaining a certain degree of flexibility and, most of all, keeping the vital organs in the vicinity relatively far away from the said tape. Furthermore, it plays a part in reconstructing the endopelvic fascia.

Claims
  • 1. A method for treating urinary incontinence in a woman, said method comprising: (a) making a vaginal incision in the region of the middle third of the urethra measured from the meatus, and(b) positioning a tape under the urethra of said woman such that one portion of said tape extends from under the urethra through one obturator foramen of said woman and another portion of said tape extends from under the urethra through the other obturator foramen of said woman.
  • 2. The method of claim 1, wherein positioning the tape further comprises using a curved needle to extend one portion of said tape from under the urethra through one obturator foramen of said woman.
  • 3. The method of claim 2, further comprising inserting a finger into said vaginal incision and guiding said curved needle to said vaginal incision.
  • 4. The method of claim 2, further comprising inserting a tapered end of said tap into an eye of said curved needle.
  • 5. The method of claim 1, further comprising cutting the ends of said tape flush with a skin surface of said woman.
  • 6. The method of claim 5, further comprising tapering the ends of said tape before cutting the ends flush with the skin surface of said woman.
  • 7. A method for treating urinary incontinence in a woman, said method comprising: (a) making a vaginal incision in the region of the middle third of the urethra measured from the meatus, and(b) positioning an elongated implant under the urethra of said woman such that one portion of said implant extends from under the urethra through one obturator foramen of said woman and another portion of said implant extends from under the urethra through the other obturator foramen of said woman.
  • 8. A method for treating urinary incontinence in women, comprising: making a median paraurethral incision, practically in the middle third of the urethra, measured from the meatus, so as to allow the insertion of an implant;inserting at least a portion of the implant through the incision; andextending each free ends of said implant respectively into a region of two obturator foramen of the iliac wing and leading them out towards the groin opposite the corresponding foramen so that they essentially form a V shape, the point of which V passes under the urethra without changing the position thereof.
  • 9. The method of claim 8, further comprising forming a space within the tissue to accommodate a portion of the implant.
  • 10. The method of claim 8, further comprising providing at least a portion of the implant that is coated with an adhesion preventing material and positioning the coated portion proximate the urethra.
  • 11. A method for treating urinary incontinence in women, comprising: making a median paraurethral incision, practically in the middle third of the urethra, measured from the meatus;passing an implant through the incision;directing a first end of the implant towards an first obturator foramen;directing a second end of the implant towards an opposite obturator foramen;securing the ends of the implant so that the implant essentially forms a V shape, the center of which passes under the urethra without changing the position thereof.
Priority Claims (1)
Number Date Country Kind
00 08706 Jul 2000 FR national
CROSS REFERENCE TO RELATED FOREIGN APPLICATIONS

This application is a continuation of U.S. application Ser. No. 10/455,465, filed Jun. 4, 2003 now abandoned, which is a divisional of U.S. application Ser. No. 10/092,069, filed Mar. 5, 2002, now U.S. Pat. No. 6,638,211, which is a continuation of International Application Serial No. PCT/FR01/02120, filed Jul. 3, 2001, which claims priority from French Patent Application Serial No. 00.08706, filed Jul. 5, 2000, and is a continuation-in-part of U.S. application Ser. No. 09/661,620, filed on Sep. 14, 2000 now abandoned. This application claims priority to each of these prior applications. In addition, the disclosure of these prior applications are considered part of (and are incorporated by reference in) the disclosure of this application.

US Referenced Citations (167)
Number Name Date Kind
2738790 Todt, Sr. et al. Mar 1956 A
3124136 Usher Mar 1964 A
3182662 Shirodkar May 1965 A
3311110 Singerman et al. Mar 1967 A
3384073 Van Winkle, Jr. May 1968 A
3472232 Earl Oct 1969 A
3580313 McKnight May 1971 A
3763860 Clarke Oct 1973 A
3789828 Schulte Feb 1974 A
3858783 Kapitanov et al. Jan 1975 A
3924633 Cook et al. Dec 1975 A
3995619 Glatzer Dec 1976 A
4019499 Fitzgerald Apr 1977 A
4037603 Wendorff Jul 1977 A
4128100 Wendorff Dec 1978 A
4172458 Pereyra Oct 1979 A
4235238 Ogui et al. Nov 1980 A
4246660 Wevers Jan 1981 A
4441497 Paudler Apr 1984 A
4509516 Richmond Apr 1985 A
4632100 Somers et al. Dec 1986 A
4775380 Seedhom et al. Oct 1988 A
4857041 Annis et al. Aug 1989 A
4865031 O'Keeffe Sep 1989 A
4920986 Biswas May 1990 A
5013292 Lemay May 1991 A
5053043 Gottesman et al. Oct 1991 A
5085661 Moss Feb 1992 A
5112344 Petros May 1992 A
5123428 Schwarz Jun 1992 A
5188636 Fedotov Feb 1993 A
5207694 Broomé May 1993 A
5209756 Seedhom et al. May 1993 A
5250033 Evans et al. Oct 1993 A
5256133 Spitz Oct 1993 A
5281237 Gimpelson Jan 1994 A
5328077 Lou Jul 1994 A
5336239 Gimpelson Aug 1994 A
5337736 Reddy Aug 1994 A
5362294 Seitzinger Nov 1994 A
5368595 Lewis Nov 1994 A
5383904 Totakura et al. Jan 1995 A
5386836 Biswas Feb 1995 A
5403328 Shallman Apr 1995 A
5413598 Moreland May 1995 A
5439467 Benderev et al. Aug 1995 A
5507796 Hasson Apr 1996 A
5520700 Beyar et al. May 1996 A
5544664 Benderev et al. Aug 1996 A
5562685 Mollenauer et al. Oct 1996 A
5562689 Green et al. Oct 1996 A
5571139 Jenkins, Jr. et al. Nov 1996 A
5591163 Thompson Jan 1997 A
5611515 Benderev et al. Mar 1997 A
5628756 Barker, Jr. et al. May 1997 A
5633286 Chen May 1997 A
5669935 Rosenman et al. Sep 1997 A
5683349 Makower et al. Nov 1997 A
5807403 Beyar et al. Sep 1998 A
5836314 Benderev et al. Nov 1998 A
5836315 Benderev et al. Nov 1998 A
5842478 Benderev et al. Dec 1998 A
5860425 Benderev et al. Jan 1999 A
5899909 Claren et al. May 1999 A
5919232 Chaffringeon et al. Jul 1999 A
5934283 Willem et al. Aug 1999 A
5935122 Fourkas et al. Aug 1999 A
5944732 Raulerson et al. Aug 1999 A
5972000 Beyar et al. Oct 1999 A
5988171 Sohn et al. Nov 1999 A
5997554 Thompson Dec 1999 A
6010447 Kardjian Jan 2000 A
6030393 Corlew Feb 2000 A
6031148 Hayes et al. Feb 2000 A
6039686 Kovac Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6042536 Tihon et al. Mar 2000 A
6048351 Gordon et al. Apr 2000 A
6050937 Benderev Apr 2000 A
6053935 Brenneman et al. Apr 2000 A
6068591 Bruckner et al. May 2000 A
6071290 Compton Jun 2000 A
6074341 Anderson et al. Jun 2000 A
6106545 Egan Aug 2000 A
6110101 Tihon et al. Aug 2000 A
6117067 Gil-Vernet Sep 2000 A
6168611 Rizvi Jan 2001 B1
6221005 Bruckner et al. Apr 2001 B1
6273852 Lehe et al. Aug 2001 B1
6302840 Benderev Oct 2001 B1
6306079 Trabucco Oct 2001 B1
6328744 Harari et al. Dec 2001 B1
6334446 Beyar Jan 2002 B1
6352553 van der Burg et al. Mar 2002 B1
6382214 Raz et al. May 2002 B1
6406423 Scetbon Jun 2002 B1
6406480 Beyar et al. Jun 2002 B1
6475139 Miller Nov 2002 B1
6478727 Scetbon Nov 2002 B2
6482214 Sidor, Jr. et al. Nov 2002 B1
6494887 Kaladelfos Dec 2002 B1
6494906 Owens Dec 2002 B1
6502578 Raz et al. Jan 2003 B2
6530943 Hoepffner et al. Mar 2003 B1
6575897 Ory et al. Jun 2003 B1
6582443 Cabak et al. Jun 2003 B2
6612977 Staskin et al. Sep 2003 B2
6638211 Suslian et al. Oct 2003 B2
6786861 Pretorius Sep 2004 B1
20010000533 Kovac Apr 2001 A1
20010018549 Scetbon Aug 2001 A1
20010039423 Skiba et al. Nov 2001 A1
20010049467 Lehe et al. Dec 2001 A1
20020007222 Desai Jan 2002 A1
20020022841 Kovac Feb 2002 A1
20020028980 Thierfelder et al. Mar 2002 A1
20020055748 Gellman et al. May 2002 A1
20020058959 Gellman May 2002 A1
20020068948 Stormby et al. Jun 2002 A1
20020072694 Snitkin et al. Jun 2002 A1
20020077526 Kammerer et al. Jun 2002 A1
20020078964 Kovac et al. Jun 2002 A1
20020082619 Cabak et al. Jun 2002 A1
20020083949 James Jul 2002 A1
20020091298 Landgrebe Jul 2002 A1
20020091373 Berger Jul 2002 A1
20020099258 Staskin et al. Jul 2002 A1
20020099259 Anderson et al. Jul 2002 A1
20020099260 Suslian et al. Jul 2002 A1
20020103542 Bilbo Aug 2002 A1
20020107430 Neisz et al. Aug 2002 A1
20020107525 Harari et al. Aug 2002 A1
20020115906 Miller Aug 2002 A1
20020119177 Bowman et al. Aug 2002 A1
20020128670 Ulmsten et al. Sep 2002 A1
20020138025 Gellman et al. Sep 2002 A1
20020147382 Neisz et al. Oct 2002 A1
20020151762 Rocheleau et al. Oct 2002 A1
20020151909 Gellman et al. Oct 2002 A1
20020151910 Gellman et al. Oct 2002 A1
20020156487 Gellman et al. Oct 2002 A1
20020156488 Gellman et al. Oct 2002 A1
20020183588 Fierro Dec 2002 A1
20020188169 Kammerer et al. Dec 2002 A1
20030004395 Therin Jan 2003 A1
20030009181 Gellman et al. Jan 2003 A1
20030023136 Raz et al. Jan 2003 A1
20030023137 Gellman Jan 2003 A1
20030023138 Luscombe Jan 2003 A1
20030036676 Scetbon Feb 2003 A1
20030050530 Neisz et al. Mar 2003 A1
20030065246 Inman et al. Apr 2003 A1
20030065402 Anderson et al. Apr 2003 A1
20030078468 Skiba et al. Apr 2003 A1
20030100954 Schuldt-Hempe et al. May 2003 A1
20030130670 Anderson et al. Jul 2003 A1
20030149440 Kammerer et al. Aug 2003 A1
20030171644 Anderson et al. Sep 2003 A1
20030176875 Anderson et al. Sep 2003 A1
20030212305 Anderson et al. Nov 2003 A1
20040097974 DeLeval May 2004 A1
20040231678 Fierro Nov 2004 A1
20040243166 Odermatt et al. Dec 2004 A1
20040249240 Goldmann et al. Dec 2004 A1
20050080317 Merade Apr 2005 A1
20050107805 Bouffier et al. May 2005 A1
20050240076 Neisz et al. Oct 2005 A1
Foreign Referenced Citations (46)
Number Date Country
2 305 815 Aug 1974 DE
4 220 283 Dec 1993 DE
4 304 353 Apr 1994 DE
0 470 308 Feb 1992 EP
0 643 945 Mar 1995 EP
0 650 703 May 1995 EP
1 093 758 Apr 2001 EP
378288 Aug 1932 GB
2187251 Aug 2002 RU
2196518 Jan 2003 RU
1 225 547 Apr 1986 SU
1 342 486 Oct 1987 SU
1475607 Apr 1989 SU
WO 9317635 Sep 1993 WO
WO 9319678 Oct 1993 WO
WO 9743982 Nov 1997 WO
WO 9819606 May 1998 WO
WO 9835606 Aug 1998 WO
WO 9835616 Aug 1998 WO
WO 9835632 Aug 1998 WO
WO 9952450 Oct 1999 WO
WO 0013601 Mar 2000 WO
WO 0018319 Apr 2000 WO
WO 0057812 Oct 2000 WO
WO 0064370 Nov 2000 WO
WO 0074594 Dec 2000 WO
WO 0074613 Dec 2000 WO
WO 0074633 Dec 2000 WO
WO-0106951 Feb 2001 WO
WO 0126581 Apr 2001 WO
WO 0139670 Jun 2001 WO
WO 0145589 Jun 2001 WO
WO-01052729 Jul 2001 WO
WO 0156499 Aug 2001 WO
WO 0202031 Jan 2002 WO
WO 0226108 Apr 2002 WO
WO 0228312 Apr 2002 WO
WO 0232284 Apr 2002 WO
WO-0232346 Apr 2002 WO
WO 0234124 May 2002 WO
WO 0239890 May 2002 WO
WO-0239890 May 2002 WO
WO-02065921 Aug 2002 WO
WO 0269781 Sep 2002 WO
WO 0271953 Sep 2002 WO
WO 0278552 Oct 2002 WO
Related Publications (1)
Number Date Country
20050131274 A1 Jun 2005 US
Divisions (1)
Number Date Country
Parent 10092069 Mar 2002 US
Child 10455465 US
Continuations (2)
Number Date Country
Parent 10455465 Jun 2003 US
Child 11040698 US
Parent PCT/FR01/02120 Jul 2001 US
Child 10092069 US
Continuation in Parts (1)
Number Date Country
Parent 09661620 Sep 2000 US
Child PCT/FR01/02120 US